Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666
What this trial is testing

Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer

Who this might be right for
Platinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca 600
Very early researchUnknownNCT05660356
What this trial is testing

Growth Hormone Deficiency in Mild Traumatic Brain Injury

Who this might be right for
Growth Hormone TreatmentGrowth Hormone DeficiencyConcussion, Mild+1 more
University of Calgary 20
Not applicableActive Not RecruitingNCT06724822
What this trial is testing

RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Aqua Medical, Inc. 12
Large-scale testing (Phase 3)Study completedNCT01318122
What this trial is testing

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 336
Post-approval studies (Phase 4)Study completedNCT02758522
What this trial is testing

NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens

Who this might be right for
Diabetes MellitusHyperglycemia
Hospital Universitario Dr. Jose E. Gonzalez 105
Early research (Phase 1)Study completedNCT03270969
What this trial is testing

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

Who this might be right for
HIV Prevention
University of Nebraska 15
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Not applicableLooking for participantsNCT07021456
What this trial is testing

Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders

Who this might be right for
Type 1 Diabetes (T1D)
University Hospital, Grenoble 100
Large-scale testing (Phase 3)Study completedNCT00462631
What this trial is testing

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients

Who this might be right for
Coronary StenosisDiabetes Mellitus
Heart Centre Rotenburg 84
Post-approval studies (Phase 4)Looking for participantsNCT07228195
What this trial is testing

SGLT2i Therapy in Islet Transplantation (SIT)

Who this might be right for
Partial Islet FunctionTPIATDiabetes
University of Minnesota 40
Testing effectiveness (Phase 2)Study completedNCT00817739
What this trial is testing

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Who this might be right for
Prostatic Neoplasms
Takeda 341
Testing effectiveness (Phase 2)Study completedNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Post-approval studies (Phase 4)Study completedNCT00449839
What this trial is testing

Changes of the Infusion Rate in Insulin Pump Treatment

Who this might be right for
Diabetes
Aarhus University Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT07066995
What this trial is testing

Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic CarcinomaPancreatic Cancer Non-resectable+1 more
Essen Biotech 60
Not applicableStudy completedNCT00410306
What this trial is testing

Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice

Who this might be right for
MaleHypogonadism
Bayer 1,493
Post-approval studies (Phase 4)Study completedNCT01202474
What this trial is testing

Apidra Children & Adolescents Study

Who this might be right for
Diabetes Mellitus, Type 1
Sanofi 100
Not applicableActive Not RecruitingNCT02400190
What this trial is testing

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Who this might be right for
Breast Neoplasms
University of Michigan Rogel Cancer Center 202
Large-scale testing (Phase 3)Study completedNCT00094991
What this trial is testing

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Bristol-Myers Squibb 42
Not applicableStudy completedNCT00327210
What this trial is testing

Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet

Who this might be right for
Type 1 Diabetes Mellitus
University of Virginia 35
Not applicableUnknownNCT01448668
What this trial is testing

Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)

Who this might be right for
Pancreas Cancer
IFAG AG 220
Next Page